Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: A double-blind, randomised controlled trial

The Lancet Infectious Diseases

Volumn 14, Issue 8, 2014, Pages 687-695

  Garcia, Hector H ^a,b,c   Gonzales, Isidro ^a   Lescano, Andres G ^b,d   Bustos, Javier A ^b   Zimic, Mirko ^b   Escalante, Diego ^e   Saavedra, Herbert ^a   Gavidia, Martin ^f   Rodriguez, Lourdes ^g   Najar, Enrique ^h   Umeres, Hugo ^h   Pretell, E Javier ⁱ  

^a INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c Universidad Peruana Cayetano Heredia   (Peru)

^d Peru   (Peru)

^e Bioinformatics Unit Laboratory of Research and Development School of Sciences and Philosophy Universidad Peruana Cayetano Heredia ^*  (Peru)

^f HOSPITAL NACIONAL EDGARDO REBAGLIATI MARTINS   (Peru)

^g HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^h HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

ⁱ HOSPITAL NACIONAL ALBERTO SABOGAL SOLOGUREN   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; PLACEBO; PRAZIQUANTEL;

ADOLESCENT; ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEADACHE; HEPATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ALBENDAZOLE; ANTHELMINTICS; DOUBLE-BLIND METHOD; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; PLACEBOS; PRAZIQUANTEL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907026825     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70779-0     Document Type: Article

References (33)

1. Garcia HH, Del Brutto OH Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005, 4:653-661.
2. Commission on Tropical Diseases of the International League Against Epilepsy. Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League Against Epilepsy. Epilepsia 1994, 35:89-93. No authors listed.
3. Flisser A Taeniasis and cysticercosis due to T solium. Progress in clinical parasitology 1994, 77-116. CRC Press, New York. T. Sun (Ed.).
4. Coyle CM, Mahanty S, Zunt JR, et al. Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis 2012, 6:e1500.
5. Gonzalez AE, Falcon N, Gavidia C, et al. Timeresponse curve of oxfendazole in the treatment of swine cysticercosis. Am J Trop Med Hyg 1998, 59:832-836.
6. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004, 350:249-258.
7. Del Brutto OH, Roos KL, Coffey CS, Garcia HH Metaanalysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006, 145:43-51.
8. Singh G, Rajshekhar V, Murthy JM, et al. A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology 2010, 75:2236-2245.
9. Otte WM, Singla M, Sander JW, Singh G Drug therapy for solitary cysticercus granuloma: a systematic review and metaanalysis. Neurology 2013, 80:152-162.
10. Sotelo J, del Brutto OH, Penagos P, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 1990, 237:69-72.
11. Botero D, Uribe CS, Sanchez JL, et al. Short course albendazole treatment for neurocysticercosis in Columbia. Trans R Soc Trop Med Hyg 1993, 87:576-577.
12. Venkatesan P Albendazole. J Antimicrob Chemother 1998, 41:145-147.
13. Harnett W The anthelmintic action of praziquantel. Parasitol Today 1988, 4:144-146.
14. Garcia HH, Lescano AG, et al. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol 2011, 72:77-84.
15. Jayakumar PN, Chandrashekar HS, Ellika S Imaging of parasitic infections of the central nervous system. Handb Clin Neurol 2013, 114:37-64.
16. Commission on classification and Terminology of the International League Against Epilepsy. Epilepsia 1981, 22:489-501. No authors listed.
17. Gonzalez AE, Falcon N, Gavidia C, et al. Treatment of porcine cysticercosis with oxfendazole: a dose-response trial. Vet Rec 1997, 141:420-422.
18. Guo DM, Xie SP, Jia JP Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi 2003, 21:187-188. (in Chinese).
19. Kaur S, Singhi P, Singhi S, Khandelwal N Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebocontrolled double blind trial. Pediatr Infect Dis J 2009, 28:403-406.
20. Wu W, Jia F, Wang W, Huang Y, Huang Y Antiparasitic treatment of cerebral cysticercosis: lessons and experiences from China. Parasitol Res 2013, 112:2879-2890.
21. Cardenas G, Carrillo Mezo R, Jung H, Sciutto E, Hernandez JL, Fleury A Subarachnoidal neurocysticercosis non responsive to cysticidal drugs: a case series. BMC Neurol 2010, 10:16.
22. Newton CR, Garcia HH Epilepsy in poor regions of the world. Lancet 2012, 380:1193-1201.
23. Mahanty S, Garcia HH Cysticercosis and neurocysticercosis as pathogens affecting the nervous system. Prog Neurobiol 2010, 91:172-184.
24. White AC, Robinson P, Kuhn R Taenia solium cysticercosis: hostparasite interactions and the immune response. Chem Immunol 1997, 66:209-230.
25. Nash TE, Singh G, White AC, et al. Treatment of neurocysticercosis: current status and future research needs. Neurology 2006, 67:1120-1127.
26. Palomares F, Palencia G, Ambrosio JR, Ortiz A, JungCook H Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studies. J Antimicrob Chemother 2006, 57:482-488.
27. Gonzalez AE, Bustos JA, Jimenez JA, et al. Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model. Am J Trop Med Hyg 2012, 87:292-296.
28. Taylor DH, Morris DL Combination chemotherapy is more effective in postspillage prophylaxis for hydatid disease than either albendazole or praziquantel alone. Br J Surg 1989, 76:954.
29. Kramer LD, Locke GE, Byrd SE, Daryabagi J Cerebral cysticercosis: documentation of natural history with CT. Radiology 1989, 171:459-462.
30. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992, 42:389-392.
31. Vazquez V, Sotelo J The course of seizures after treatment for cerebral cysticercosis. New Engl J Med 1992, 327:696-701.
32. Carpio A, Santillan F, Leon P, Flores C, Hauser WA Is the course of neurocysticercosis modified by treatment with antihelminthic agents?. Arch Intern Med 1995, 155:1982-1988.
33. Garcia HH, Gonzalez AE, Gilman RH Cysticercosis of the central nervous system: how should it be managed?. Curr Opin Infect Dis 2011, 24:423-427.